MEDNATION AG (EIF.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:EIF • DE0005653604

3.12 EUR
-0.06 (-1.89%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

3

EIF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 33 industry peers in the Health Care Providers & Services industry. While EIF seems to be doing ok healthwise, there are quite some concerns on its profitability. EIF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • EIF had positive earnings in the past year.
  • EIF had a positive operating cash flow in the past year.
  • In multiple years EIF reported negative net income over the last 5 years.
  • Each year in the past 5 years EIF had a positive operating cash flow.
EIF.DE Yearly Net Income VS EBIT VS OCF VS FCFEIF.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

  • EIF's Return On Assets of 1.58% is on the low side compared to the rest of the industry. EIF is outperformed by 60.61% of its industry peers.
  • Looking at the Return On Equity, with a value of 4.66%, EIF is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • EIF has a worse Return On Invested Capital (1.64%) than 78.79% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EIF is below the industry average of 5.90%.
Industry RankSector Rank
ROA 1.58%
ROE 4.66%
ROIC 1.64%
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
EIF.DE Yearly ROA, ROE, ROICEIF.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • EIF has a Profit Margin of 1.13%. This is comparable to the rest of the industry: EIF outperforms 42.42% of its industry peers.
  • With a Operating Margin value of 2.34%, EIF is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
  • EIF's Operating Margin has declined in the last couple of years.
  • EIF's Gross Margin of 91.35% is amongst the best of the industry. EIF outperforms 90.91% of its industry peers.
  • In the last couple of years the Gross Margin of EIF has remained more or less at the same level.
Industry RankSector Rank
OM 2.34%
PM (TTM) 1.13%
GM 91.35%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
EIF.DE Yearly Profit, Operating, Gross MarginsEIF.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • EIF has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • EIF has less shares outstanding than it did 1 year ago.
  • EIF has less shares outstanding than it did 5 years ago.
  • EIF has a better debt/assets ratio than last year.
EIF.DE Yearly Shares OutstandingEIF.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
EIF.DE Yearly Total Debt VS Total AssetsEIF.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 1.95 indicates that EIF is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • EIF has a Altman-Z score of 1.95. This is comparable to the rest of the industry: EIF outperforms 54.55% of its industry peers.
  • EIF has a Debt/Equity ratio of 0.98. This is a neutral value indicating EIF is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.98, EIF is in line with its industry, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.95
ROIC/WACC0.38
WACC4.36%
EIF.DE Yearly LT Debt VS Equity VS FCFEIF.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • EIF has a Current Ratio of 1.73. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
  • EIF's Current ratio of 1.73 is fine compared to the rest of the industry. EIF outperforms 78.79% of its industry peers.
  • EIF has a Quick Ratio of 1.50. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of EIF (1.50) is better than 84.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.5
EIF.DE Yearly Current Assets VS Current LiabilitesEIF.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • EIF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.51%.
  • The Revenue has been growing slightly by 4.11% in the past year.
  • Measured over the past years, EIF shows a small growth in Revenue. The Revenue has been growing by 0.13% on average per year.
EPS 1Y (TTM)-56.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
Revenue 1Y (TTM)4.11%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%4.89%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EIF.DE Yearly Revenue VS EstimatesEIF.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.42, EIF is valued correctly.
  • Based on the Price/Earnings ratio, EIF is valued a bit cheaper than the industry average as 60.61% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, EIF is valued a bit cheaper.
Industry RankSector Rank
PE 16.42
Fwd PE N/A
EIF.DE Price Earnings VS Forward Price EarningsEIF.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • EIF's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.19
EIF.DE Per share dataEIF.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for EIF!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MEDNATION AG

FRA:EIF (2/5/2026, 7:00:00 PM)

3.12

-0.06 (-1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-30
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.13%
Ins Owner ChangeN/A
Market Cap9.73M
Revenue(TTM)50.89M
Net Income(TTM)575.90K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.42
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF 25.42
P/B 0.79
P/tB 0.79
EV/EBITDA 10.19
EPS(TTM)0.19
EY6.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.12
OCFY3.93%
SpS16.31
BVpS3.96
TBVpS3.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.12
Profitability
Industry RankSector Rank
ROA 1.58%
ROE 4.66%
ROCE 3.86%
ROIC 1.64%
ROICexc 1.8%
ROICexgc 1.8%
OM 2.34%
PM (TTM) 1.13%
GM 91.35%
FCFM N/A
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)1.97%
ROICexgc(5y)N/A
ROCE(3y)4.15%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y6.43%
ROICexc growth 3YN/A
ROICexc growth 5Y6.41%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
F-Score5
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 6.43
Cap/Depr 60.09%
Cap/Sales 0.81%
Interest Coverage 3.91
Cash Conversion 20.4%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.5
Altman-Z 1.95
F-Score5
WACC4.36%
ROIC/WACC0.38
Cap/Depr(3y)35.94%
Cap/Depr(5y)25.78%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.11%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%4.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.69%
EBIT growth 3YN/A
EBIT growth 5Y-8.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-112.02%
FCF growth 3Y-18.54%
FCF growth 5Y-3.22%
OCF growth 1Y-40.8%
OCF growth 3Y-13.99%
OCF growth 5Y-5.06%

MEDNATION AG / EIF.DE FAQ

Can you provide the ChartMill fundamental rating for MEDNATION AG?

ChartMill assigns a fundamental rating of 3 / 10 to EIF.DE.


What is the valuation status for EIF stock?

ChartMill assigns a valuation rating of 2 / 10 to MEDNATION AG (EIF.DE). This can be considered as Overvalued.


Can you provide the profitability details for MEDNATION AG?

MEDNATION AG (EIF.DE) has a profitability rating of 3 / 10.


What are the PE and PB ratios of MEDNATION AG (EIF.DE) stock?

The Price/Earnings (PE) ratio for MEDNATION AG (EIF.DE) is 16.42 and the Price/Book (PB) ratio is 0.79.


How financially healthy is MEDNATION AG?

The financial health rating of MEDNATION AG (EIF.DE) is 5 / 10.